Decision Diagnostics Corp (DECN)

[Leirum]

Well the word "we anticipate" and "intent" means what it says:

We anticipate a universe, where we are the only participant, generating about $75,000,000 in annual revenues and $15 million in annual profits, all low hanging fruit, available for us to seize through this social media campaign. We intend to capture all of it."


Bermans Statement from November 5, 2014 is not different from Statements made by other CEO's or politicians. This is a Forward looking Statements and as we all know, in between a lot of things may happen, that time schedules become streteched due to unforseen envents. . But there is a difference between being active or passive and DECN despite various setbacks is on the move.

With the tailwind of the Koreans DECN may indeed conquer the market and grab an attractive slice out of the cake. And what is actually $ 75 Mio in Revenues from the Overall turnover in this market?

Taking this Statement:

The global blood glucose monitoring devices market is expected to reach a value of $12.2 billion in 2017, with a predicted CAGR of 4.5% between 2010 and 2017. The blood glucose test strips market segment is expected to be valued at $10.9 billion in 2017 and is forecast to exhibit a CAGR of 4.6% between 2010 and 2017. High Prevalence of Diabetes is Leading to Patients Opting for Blood Glucose Monitoring Devices

As can be seen, even in a Statement from a world-known Organisation, the wording is "expected" which is a synonym of "anticipate" and if I take the $ 10.9 Billion figure from this forecast as Basis to the expectation of K.B. then we are talking about 0.7% market share. I would say, nobody can say that KB exaggerated on the contrary.